US FDA

The U.S. health regulator revised on Monday the emergency use authorizations for COVID-19 antibody treatments from Regeneron and Eli Lilly to limit their use, as the drugs are unlikely to work against the Omicron coronavirus…

NEW YORK: The US FDA has authorised the use of a third dose of the Pfizer and BioNTech Covid-19 vaccine for children aged between 12 and 15 years, and narrowed the time for all booster shots by a month to five months after the primary…

<!-- -->New Delhi: Homegrown pharma major Lupin Ltd on Tuesday said it has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its Goa manufacturing facility after an inspection in…

U.S. regulators on Friday opened up COVID-19 booster shots to all adults, expanding the government’s campaign to shore up protection and get ahead of rising coronavirus cases that may worsen with the holidays.Pfizer and Moderna announced…

Bloomberg | | Posted by Sharangee Dutta, Hindustan Times, New Delhi Moderna Inc. lost more than $7 billion in market value on Monday after its Covid-19 shot failed to secure US regulatory authorisation in teenagers.The Food and Drug…

U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday. The U.S. Food and Drug Administration told the…

U.S. health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the…

The US Food and Drug Administration (FDA) on Wednesday authorised booster doses of the Covid-19 vaccines from Moderna Inc and Johnson & Johnson, and said Americans can choose a different shot than their original inoculation as a…

By Matthew Perrone And Lauran Neergaard The Associated Press Posted October 20, 2021 1:02 pm …

<!-- -->Boosters for Pfizer are currently being debated by a separate body of experts in US (Representational)Washington: The United States on Wednesday authorized the use of boosters of Pfizer's Covid-19 vaccine for people aged over…